RGS12 and Alzheimer disease: For the continuous AD CSF biomarkers, only one of the top 10 CpG sites from the epigenome-wide meta-analysis was at least nominally significant (unadjusted p-value < 0.05) in both cohorts, namely cg05104523 (RGS12), which was among the top ten CpG sites for tTau and pTau, For the categorial outcomes of Aβ42+/− and pTau+/−, several of the top 10 CpG sites from the epigenome-wide meta-analysis were at least nominally significant (unadjusted p-value < 0.05) in both cohorts.